uspto.gov
Skip over navigation

Biotechnology/Chemical/Pharmaceutical Customer Partnership

Wednesday, September 5, 2012
9:00am to 5:00 PM

United States Patent and Trademark Office
Alexandria, Virginia

Madison Auditorium
600 Dulany Street, Alexandria, VA

 

The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on June 6, 2012 at the U.S. Patent and Trademark Office.  The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO.  The USPTO does not intend to use these customer partnership groups to arrive at any consensus.  Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants.  These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.                                                          

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services.  Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.

 

The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Wednesday, September, 2012 from 9:00 am to 5:00 PM at Auditorium in Madison East, 600 Dulany Street, Alexandria, Virginia. 

 

For information of future meetings and presentations, please go to http://www.cabic.com/bcp/.

  

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by August 31, 2012.  

Agenda and Schedule for the Biotechnology and Chemical Pharmaceutical Customer Partnership Meeting

Morning Session

 9:00 - 9:15

Opening Remarks

George Elliott, Wanda Walker and Peter Paras (Acting), Directors,  TC1600

 9:15 - 10:15

Recent Examiner Training and Developments Under 35 USC 101

Andrew Hirshfeld, Deputy  Commissioner for Patent  Examination Policy

10:15 - 10:30

Break

 

10:30 - 11:15

Professional Responsibilities for IP Practitioners

William Covey, Office of Enrollment and   
Discipline

11:15 - 12:00

New Board Proceedings Mandated by the AIA

Sally Lane, APJ  PTAB (BPAI)

12:00 - 12:45

AIA Oath/Declaration Changes

Hiram Bernstein, OPLA

12:45 - 1:45                                                                                                   Lunch

Afternoon Session

1:45 - 2:30

First Inventor to File

Mary Till, OPLA

2:30 - 3:15

Quality Composite

Martin Rater, Office of Patent Quality Assurance

3:15 - 4:00

Break

 

4:00 - 4:45

Civility in Communication between the Applicant and the Examiner

Esther Kipllinger, Chief Patent  Counselor, Wilson Sosini Goodrich & Rossi

4:45 - 5:00

Closing remarks and Discussion

George Elliott, Wanda Walker and Peter Paras (Acting), Directors,  TC1600

 

Back to top

Accessing the event online via WebEx

To join the online event, please click on the link below:

https://uspto-events.webex.com/uspto-events/onstage/g.php?t=a&d=991681937

To Join Captions, please click on the link below:
 
http://www.captionedtext.com/client/embed.aspx?EventID=2014603

-------------------------------------------------------

For assistance

-------------------------------------------------------

You can contact USPTO WebEx at:

richard.lehman@uspto.gov

http://www.webex.com

IMPORTANT NOTICE: This WebEx service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this session, you automatically consent to such recordings. If you do not consent to the recording, discuss your concerns with the meeting host prior to the start of the recording or do not join the session. Please note that any such recordings may be subject to discovery in the event of litigation.

 

Back to top

United States Patent and Trademark Office
This page is owned by Technology Center 1600.
Last Modified: 9/4/2012 2:58:10 PM